Concepedia

Author

Archie Bleyer

The University of Texas MD Anderson Cancer Center

Also Known As

A Bleyer, A W Bleyer, A. Bleyer, Archie Bleyer, Archie W. Bleyer

43

Publications

8.9K

Citations

18

H-Index

41

Concepts

All Affiliations

The University of Texas MD Anderson Cancer CenterInstitute for Health Metrics and EvaluationChildren's Hospital of PhiladelphiaUniversity of Washington
AB

About

Archie Bleyer is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and radiation oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

7

7

1.4K

2

Health Sciences

2

2

229

3

Public Health

1

1

839

4

Epidemiology

1

1

839

5

Global Health

1

1

839

Archie Bleyer

×

17

Publications

8.4K

Citations

15

H-Index

YearCitations

Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

Jeffrey D Stanaway, Ashkan Afshin, Emmanuela Gakidou,

The Lancet

2018

4.9K

Global, regional, and national age-sex-specific mortality and life expectancy, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017

Daniel Dicker, Grant Nguyen, Degu Abate,

The Lancet

2018

1.2K

Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021

Austin E Schumacher, Hmwe Hmwe Kyu, Amirali Aali,

The Lancet

2024

839

Population and fertility by age and sex for 195 countries and territories, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017

Christopher J L Murray, Charlton Callender, Xie Rachel Kulikoff,

The Lancet

2018

478

National-level and state-level prevalence of overweight and obesity among children, adolescents, and adults in the USA, 1990–2021, and forecasts up to 2050

Marie Ng, Xiaochen Dai, Rebecca M Cogen,

The Lancet

2024

235

Improved disease-free survival of children with acute lymphoblastic leukemia at high risk for early relapse with the New York regimen--a new intensive therapy protocol: a report from the Childrens Cancer Study Group.

P. Steinherz, Paul S. Gaynon, Donald R. Miller,

Journal of Clinical Oncology

1986

174

Report and recommendations of the rome workshop concerning poor‐prognosis acute lymphoblastic leukemia in children: Biologic bases for staging, stratification, and treatment

Renato Mastrangelo, David G. Poplack, Archie Bleyer,

Medical and Pediatric Oncology

1986

167

Leukemic cell growth in SCID mice as a predictor of relapse in high- risk B-lineage acute lymphoblastic leukemia

Harland N. Sather, Gregory H. Reaman, Jonathan J. Shuster,

Blood

1995

101

Phase III Prevention Trial of Fenretinide in Patients with Resected Non–Muscle-Invasive Bladder Cancer

Anita L. Sabichi, Seth P. Lerner, E. Neely Atkinson,

Clinical Cancer Research

2008

69

A multi-center phase II study of sequential paclitaxel and bryostatin-1 (NSC 339555) in patients with untreated, advanced gastric or gastroesophageal junction adenocarcinoma

Jaffer A. Ajani, Yixing Jiang, Josephine Faust,

Investigational New Drugs

2006

66

Page 1